Paper8097924
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.
Dei Cas L and 3 others. Cardiovasc Drugs Ther, 1993. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. Papers, record 8097924. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097924
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Exercise | Major topic |
| Heart Failure | Major topic |
| Hemodynamics | Major topic |
| Neurotransmitter Agents | Major topic |
| Nisoldipine | Major topic |
| Rest | Major topic |
| Adult | |
| Aged | |
| Chronic Disease | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2882868 | Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. | Circulation | 1987 | https://conductscience.org/library/papers/2882868 | PubMed |
| 2 | 2808990 | Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. | J Am Coll Cardiol | 1989 | https://conductscience.org/library/papers/2808990 | PubMed |
| 3 | 6488501 | Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure. | Circulation | 1984 | https://conductscience.org/library/papers/6488501 | PubMed |
| 4 | 1967559 | Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. | Circulation | 1990 | https://conductscience.org/library/papers/1967559 | PubMed |
| 5 | 7415993 | Hemodynamic effects of nifedipine in congestive heart failure. | Am J Cardiol | 1980 | https://conductscience.org/library/papers/7415993 | PubMed |
| 6 | 2459547 | Intravenous nisoldipine in severe congestive heart failure. | J Cardiovasc Pharmacol | 1988 | https://conductscience.org/library/papers/2459547 | PubMed |
| 7 | 3310565 | Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure. | Am Heart J | 1987 | https://conductscience.org/library/papers/3310565 | PubMed |
| 8 | 2242521 | A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. | Circulation | 1990 | https://conductscience.org/library/papers/2242521 | PubMed |
| 9 | 2880884 | Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. | J Am Coll Cardiol | 1987 | https://conductscience.org/library/papers/2880884 | PubMed |
| 10 | 2878602 | Coronary and systemic hemodynamic effects of intravenous nisoldipine. | Am J Cardiol | 1986 | https://conductscience.org/library/papers/2878602 | PubMed |
| 11 | 2330899 | Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure. | Am J Cardiol | 1990 | https://conductscience.org/library/papers/2330899 | PubMed |
| 12 | 7194077 | Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). | Arzneimittelforschung | 1980 | https://conductscience.org/library/papers/7194077 | PubMed |
| 13 | 2688986 | Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. | Circulation | 1989 | https://conductscience.org/library/papers/2688986 | PubMed |
| 14 | 6684444 | Hemodynamic effects of nisoldipine in chronic congestive heart failure. | Arzneimittelforschung | 1983 | https://conductscience.org/library/papers/6684444 | PubMed |
| 15 | 7261283 | Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy. | Circulation | 1981 | https://conductscience.org/library/papers/7261283 | PubMed |
| 16 | 1729848 | Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function. | Am Heart J | 1992 | https://conductscience.org/library/papers/1729848 | PubMed |
| 17 | 6085356 | Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. | J Cardiovasc Pharmacol | 1984 | https://conductscience.org/library/papers/6085356 | PubMed |
| 18 | 6466518 | Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure. | Br Heart J | 1984 | https://conductscience.org/library/papers/6466518 | PubMed |
| 19 | 3973272 | Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. | J Am Coll Cardiol | 1985 | https://conductscience.org/library/papers/3973272 | PubMed |
| 20 | 6741802 | Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. | Am J Cardiol | 1984 | https://conductscience.org/library/papers/6741802 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8485072 | Calcium antagonists for congestive heart failure: is it really one bridge too far to cross? | Cardiovasc Drugs Ther | 1993 | https://conductscience.org/library/papers/8485072 | PubMed |
| 7947378 | Cardioselectivity of calcium antagonists. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/7947378 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8097924
GET https://conductscience.org/api/papers/v1/8097924/references?page=2